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this arthritis model inflammation was increased in TLR2-/- mice.
In contrast, inflammation in TLR4-/- mice was decreased in the
arthritis model. However, in experimental OA in all strains, no
obvious differences in inflammation were found, so mechanisms
of action of TLR deficiencies in OA are probably unrelated to
inflammation.
Conclusions: In contrast to our expectations, these studies
indicate that both in TLR2 and TLR4 deficient mice OA pathology
is more severe when experimental OA is induced. This suggest
protective roles for both receptors in OA, in stead of the inducing
roles that were anticipated. The mechanisms via which TLR2 and
4 exert this effect remain unclear, although stimulation of TLR2
and 4 by endogenous ligands such as biglycan has been shown
to induce IL-10, TGFβ and HGF, which are protective mediators
for OA. The differences in preference for the joint compartment
may indicate different mechanisms, or differences in TLR2 and
4 distribution in the cartilage, but may also reflect strain related
differences. Although further research is needed, these results
indicate that during OA certain TLR pathways protect cartilage
from developing OA which may lead to clues for future therapy.
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Purpose: One of the most important alternative splicing events
identified in connective tissue biology is the developmentally-
regulated processing of COL2A1. Here, exon 2, encoding a
cysteine-rich domain in the N-propeptide, is included in or ex-
cluded from mature mRNA producing type IIA (+ exon 2 in
chondroprogenitor cells) or type IIB procollagen (-exon 2 in dif-
ferentiated chondrocytes) (Fig.1A). We recently identified a novel
cis element in intron 2 of COL2A1 (Fig.1B) and proceeded to
investigate what trans-acting factors bind to this U-rich region.
We chose the arthritis suppressor RNA binding protein, TIA-1
(T-cell intracellular antigen 1), as a potential candidate as it has
been shown to regulate alternative splicing of other genes by
interacting with U-rich intronic sequences.
Methods: A COL2A1 mini-gene (Fig.1A) was co-transfected with
a TIA-1-encoding cDNA construct into different chondrocyte and
non-chondrocyte cells. RT-PCR of harvested mRNA was done
using primers specific for the COL2A1 mini-gene (Fig. 1A). IIA
and IIB cDNA isoforms were analyzed by phosphor-imaging.
TIA-1 was co-transfected with COL2A1 mini-genes containing
mutations in the T/U-rich region. Endogenous TIA-1 mRNA or
protein was analyzed by RT-PCR or Western blotting of nuclear
extracts. A GST/TIA-1 fusion protein was synthesized and used
in binding assays with radio-labelled RNA or DNA probes cor-
responding to the T/U-rich 38 nucleotide cis element (Fig.1B).
Electromobility shift or UV cross-linking assays were done to
detect protein/probe complexes in the presence or absence of
various competitors. Chromatin or RNA immunoprecipitation as-
says were done to confirm in vivo interaction of genomic DNA or
pre-mRNA with endogenous TIA-1 protein in the nucleus.
Results: TIA-1 regulated alternative splicing by increasing the
IIA mRNA isoform (+exon 2) in human chondrocytes and non-
chondrocytes. These cells also contained the highest levels of
endogenous TIA-1 compared to other cell types analyzed. Co-
transfection of TIA-1 with mutant COL2A1 mini-genes suggested
that the U-rich stretch (AUUUAUUUAUUU) was a potential TIA-1
RNA binding site. This was confirmed by RNA/protein binding
assays. GST/TIA-1 fusion protein interacted with the wild-type
RNA probe, but not with a mutant probe containing nucleotide
substitutions in the U-rich region. Interestingly, TIA-1 was found
to bind to the equivalent DNA T-rich probe, with a preference
for single-stranded rather than double-stranded DNA. The DNA
probe bound to TIA-1 with higher affinity than RNA yet, in
both cases, the major TIA-1 binding site was in the T/U-rich
region. Immunoprecipitation assays confirmed in vivo binding of
endogenous TIA-1 to COL2A1 genomic DNA and pre-mRNA.
Conclusions: This is the first report indicating TIA-1 as a reg-
ulator of COL2A1 alternative splicing. We also report a novel
function for TIA-1 by its ability to bind genomic DNA as well as
RNA. We suggest TIA-1 has a dual role in regulating COL2A1
expression by functioning at the level of transcription and pre-
mRNA splicing. TIA-1 is known to down-regulate expression
of the inflammatory mediators TNF-α and COX-2 by binding
adenylate/uridylate rich elements (AREs) in the 3’ untranslated
region of mRNA. These AREs contain repeats of the AUUUA
pentameric sequence also found in the COL2A1 cis element de-
scribed here. Since expression of the embryonic type IIA isoform
has been detected in osteoarthritic cartilage, TIA-1 may function
in promoting a tissue repair response by altering expression of
specific cartilage matrix protein isoforms in addition to repressing
inflammatory cytokine expression.
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Purpose: F-spondin, first identified as a novel protein secreted
by neuronal cells, is a member of a family of proteins that collec-
tively belong to a subgroup of TSR (thrombospondin) type I class
molecules. We have discovered, using Affymetrix microarray
screening followed by confirmatory immunoblot and immunohis-
tochemistry, that F- spondin expression is significantly increased
in osteoarthritic cartilage. We here report studies designed to
elucidate its role.
Methods: Gene expression studies of cartilage from normal and
OA patients were performed using Affymetrix U95Av2 microarray.
The microarray data was normalized and analyzed using dchip
program. The differentially expressed gene was confirmed using
TaqMan Real Time PCR. Chondrocytes were isolated from OA
patients undergoing joint replacement surgery, using collagenase
digestion and cultured in monolayer. Prostaglandin E2 (PGE2),
was estimated using radioimmunoassay. The active and total
TGF-b1 was estimated using R&D systems ELISA kits.
Results: We studied the expression of F-spondin in 18 OA and
8 age-matched normal cartilage and synovium using Affymetrix
microarray. The OA specimens were obtained at the time of
joint replacement surgery and the normal tissues from acci-
dent victims. F-spondin was overexpressed in OA chondrocytes
(2-5 fold). The differential expression of F-spondin in cartilage
was confirmed by real time PCR and western blot. The expres-
sion of F-spondin in OA cartilage was also confirmed by im-
munostaining. F-spondin mRNA expression was also increased
in rat meniscectomy model of OA and expressed in hypertrophic
and calcified zones of chick embryonic growth plates. Unstimu-
lated chondrocytes constitutively expressed F-spondin, which de-
creased following exposure to IL-1 (10 ng/ml). In contrast, PGE2
(1-10 uM), significant increased F-spondin expression from 4-
48h following stimulation. This effect could be mimicked by the
cAMP analog, dibutyryl cAMP. Addition of F-spondin increased
PGE2 production in chondrocytes, which could be inhibited by
avb3 integrin blocking antibody LM609. Addition of growth fac-
tors FGF-basic, FGF-18 and TGF-b, enhanced the expression
